Survey and Cognitive Behavior Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
NCT ID: NCT00920777
Last Updated: 2020-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
234 participants
INTERVENTIONAL
2009-05-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Web-based Cognitive Behavioural Treatment for Adolescents With Chronic Fatigue Syndrome
NCT00893438
Biopsychological Intervention in Chronic Fatigue Syndrome - a Pilot Study
NCT02336126
Exploring Worry in CFS/ME
NCT06011135
Mental Training for CFS Following EBV Infection in Adolescents
NCT02499302
Blended Cognitive Behavioural Therapy Versus Face-to-face Cognitive Behavioural Therapy
NCT02796573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
8 weeks CBT
CBT
Individual Cognitive Behavior Therapy during 8 weeks
Control group
Control group
Waiting 16 weeks and receiving 8 weeks individual CBT after waiting period.
16 weeks CBT
CBT
Individual Cognitive Behavior Therapy during 16 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT
Individual Cognitive Behavior Therapy during 16 weeks
CBT
Individual Cognitive Behavior Therapy during 8 weeks
Control group
Waiting 16 weeks and receiving 8 weeks individual CBT after waiting period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fulfil the FUKUDA criteria for CFS/ME.
Exclusion Criteria
18 Years
62 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Egil Fors, prof MD
Role: PRINCIPAL_INVESTIGATOR
St. Olavs Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St.Olavs Hospital
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rasouli O, Gotaas ME, Stensdotter AK, Skovlund E, Landro NI, Dastol P, Fors EA. Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings. Neuropsychology. 2019 Jul;33(5):658-669. doi: 10.1037/neu0000550. Epub 2019 Jun 6.
Gotaas ME, Stiles TC, Bjorngaard JH, Borchgrevink PC, Fors EA. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions. Front Psychiatry. 2021 Apr 12;12:580924. doi: 10.3389/fpsyt.2021.580924. eCollection 2021.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21592
Identifier Type: OTHER
Identifier Source: secondary_id
4.2008.2586
Identifier Type: OTHER
Identifier Source: secondary_id
21592
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.